Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma

BACKGROUND: In metastatic pancreatic adenocarcinoma, few data are available on the use of granulocyte-colony stimulating factor (G-CSF) prophylaxis and its impact on dose-intensity (DI), or the link between DI and progression-free survival (PFS). This study assessed the impact of G-CSF prophylaxis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Canton, Clémence, Boussari, Olayidé, Boulin, Mathieu, Le Malicot, Karine, Taieb, Julien, Dahan, Laetitia, Lopez, Anthony, Lepage, Come, Bachet, Jean-Baptiste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255980/
https://www.ncbi.nlm.nih.gov/pubmed/35289915
http://dx.doi.org/10.1093/oncolo/oyac055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255980/
https://www.ncbi.nlm.nih.gov/pubmed/35289915
http://dx.doi.org/10.1093/oncolo/oyac055

Ejemplares similares